Abstract:Background: Empirical use of Hydroxychloroquine (HCQ) in patients with positive antinuclear antibody spectrum (ANAs) test result is controversial regarding its impact on improving perinatal outcomes. This study aimed to investigate the effect of HCQ on adverse pregnancy outcomes associated with placental dysfunction in ANAs-positive patients. Methods: The study included pregnant women with positive ANAs test result from 2016 to 2020 in our center, and divided into a weakly positive and a positive group in just ANA positive patients among them. Univariate and multivariate analyses were conducted to determine the effect of HCQ on pregnancy outcomes in each subgroup. Stratified and interactive analyses were performed to assess the value of HCQ in improving pregnancy outcomes. Results: (i) A total of 261 cases were included, accounting for 30.60% of pregnancy complicated with autoimmune abnormalities, and 65.12% of them used HCQ during pregnancy. (ii) The application of HCQ significantly reduced the incidence of early-onset preeclampsia (1.18% vs. 12.09%, p = 0.040) and small-for-gestational-age infants (10.06% vs. 25.84%, p = 0.003) in the ANAs-positive population, increased birth weight (3075.87 ± 603.91 g vs. 2847.53 ± 773.73 g, p = 0.025), and prolonged gestation (38.43 ± 2.31 vs. 36.34 ± 5.45 weeks, p < 0.001). (iii) A total of 185 just ANA-positive patients were stratified according to titers. Among them, the rate of HCQ usage was significantly higher than that in the weakly positive group (81.03% vs. 58.27%, p = 0.003). (vi) Stratified univariate analysis showed that HCQ usage in the ANA-positive group could reduce the incidence of preeclampsia (2.13% vs. 27.27%, p = 0.019) and prolong gestation (38.29 ± 2.54 vs. 34.48 ± 7.68 weeks, p = 0.006). In the ANA-weakly positive group, HCQ significantly reduced the incidence of preeclampsia (6.76% vs. 28.30%, p = 0.002), early-onset preeclampsia (1.35% vs. 13.21%, p = 0.027), and small-for-gestational-age infants (7.89% vs. 35.19%, p < 0.001). Multivariate regression analysis showed that HCQ significantly reduced the incidence of preeclampsia in both groups. Intergroup interaction analysis showed no significant difference in the value of HCQ in reducing the incidence of preeclampsia between the two groups. Conclusion: ANAs positivity is an important abnormal autoimmunity type in pregnancy. HCQ can be considered as a choice for improving adverse pregnancy outcomes related to placental dysfunction, such as preeclampsia, in this population.

Relationship Between the Expression of Antinutrophil C Ytoplasmic Antibodies and Pregnancy-Induced Hypertension

Relationship Between Expression of Vimentin, Type IV Collagen and Fibronectin in Human Placenta and Pregnancy Induced Hypertension

Expression of Two Primary Target Antigens （PR3 and MPO） of Serum Antinutrophil Cytoplasmic Antibodies in Severe Preeclampsia Women

Research Progress on the Relationship between Anticardiolipin Antibodies and Adverse Pregnancy Outcomes

Risk Factors and Potential Protective Factors of Pregnancy-Induced Hypertension in China: A Cross-Sectional Study

Association of Anti‐Annexin A5 Antibody With Pregnancy Outcomes: A Cohort Study

Association of Anti-Annexin A5 Antibody With Pregnancy Outcomes: A Cohort Study: Anti-annexin A5 antibody with pregnancy outcomes

Imbalance of Serum T Helper 1- and 2-Type Cytokines in Preeclampsia and Gestational Hypertension

Alteration of Serum Endocan in Normal Pregnancy and Preeclampsia

Hydroxychloroquine improves pregnancy outcomes of women with positive antinuclear antibody spectrum test results

Expression of Placental Vascular Growth Factor in Pregnancy-Induced Hypertension

[Association Between Pregnancy-Induced Hypertension, Cesarean Delivery and Perinatal Mortality: a Prospective Study].

Study on Relationship Between the Levels of Interleukin-6 and Immunoglobulin in Maternal and Umbilical Serum of Pregnancy Induced Hypertension

Placental Imbalance of Th1‐ and Th2‐type Cytokines in Preeclampsia

Elevated Serum Levels of Interleukin-15 and Interleukin-16 in Preeclampsia.

Relationship Between Pregnancy Associated Plasma Protein A and Blood Pressure in Patients with Essential Hypertension

Correlation between the expression of inflammatory cytokines IL-6, TNF-α and hs-CRP and unfavorable fetal outcomes in patients with pregnancy-induced hypertension

[Association of Pregnancy-Induced Hypertension with Small-for-gestational-age Babies].

The Association between Gut Microbiome and Pregnancy-Induced Hypertension: A Nested Case-Control Study

Relationship between intercellular adhesion molecule-1 and the occurrence of hypertensive disorder complicating pregnancy

Meta-analysis of the Relationship between Serum Chorionic Gonadotropin and Hypertensive Disorder in Pregnancy and Preeclampsia